T +44 20 7532 1297
Nicola Chapman is an associate in the Firm's Banking Practice in London. Nicola's experience includes advising on a range of domestic and cross-border transactions including acquisition finance and general bank lending acting for private equity sponsors, their portfolio companies, other borrowers and banks.
Prior to joining White & Case in August 2015, Nicola worked in the banking team of a magic circle firm in London. During this time Nicola spent six months on secondment to the capital markets origination team at Citibank and nine months on secondment to the loan markets team at The Royal Bank of Scotland plc, as well as spending six months working in her previous firm's banking team in Singapore.
Advised a consortium including Bridgepoint on the debt financing for a $1 billion (SEK 9.2 billion) public takeover offer for Cherry AB.
Advised CVC Capital Partners on the €3.4 billion bridge to bond facilities and €250 million revolving credit facilities, for its acquisition from the Recordati family of the holding company that owns a 51.8 percent stake in the Italian pharmaceutical group Recordati and subsequent public takeover offer for the remaining shares.
Advised CVC on the €810 million senior facilities and €200 million second lien facility for its acquisition of the Mehiläinen Group.
Advised JP Morgan Chase, Deutsche Bank, Goldman Sachs and Jefferies as mandated lead arrangers in connection with the senior debt financing for EQT's acquisition of SUSE, which included a €675 million covenant lite TLB and a $81 million revolving credit facility
Advised P4 Sp z. o.o and its shareholders in relation to its PLN 7bn (approximately €1.65 billion) loan and €500 million notes refinancing and recapitalisation.
Advised GSO in relation to its financing of Advent's acquisition of Brammer Limited (formerly Brammer plc).
Advised Bridgepoint on its £425 million term loan B financing (and £110 million undrawn facilities) for the acquisition of Zenith – the largest ever Sterling unitranche financing.
Advised in relation to Keter Group's acquisition by BC Partners Ltd and the Public Sector Pension Investment Board of a majority stake in the group from the Sagol family. The transaction is the biggest ever LBO in Israel and has been described as the "deal of the decade" in the Israeli press.
Advised the lenders in relation to the financing of the IBA Molecular's (a portfolio of CapVest) carve-out acquisition from Mallinckrodt Plc of its global nuclear imaging radiopharmaceuticals division.